InSphero partners with leading biotechnological and pharmaceutical companies, academic institutions and research organizations, to advance scientific research and drug development. Through these collaborations, we drive further the development of scalable, reliable and reproducible 3D cell-based solutions that help researchers yield pragmatic and actionable insights for better and faster decisions.
InSphero has established dynamic partnerships with biotechnological companies, marking a crucial stride in advancing cutting-edge drug research and development. Through joint efforts, we converge our strengths to create industry-ready platforms and solutions that mimic human biology more accurately, thus revolutionizing preclinical testing, drug efficacy evaluation, and toxicity assessments.
ATCC and InSphero have formed a strategic partnership that is set to redefine standards and introduce new paradigms in the rapidly evolving field of 3D cell–based oncology research.
By combining the power of ATCC's gold-standard, authenticated cell lines with InSphero's innovative, industry-leading 3D cell-based assay platforms, the scientific community will gain unprecedented access to assay-ready 3D tumor microtissues that will help accelerate oncology research at a global scale. This partnership will also provide an expansive and diverse portfolio of tumor models in easy-to-use and workflow-ready formats, ensuring researchers have access to enriched data sets that underpin better decision-making in drug safety and efficacy.
Read the press release to learn more about the partnership
Biognosys is a leading proteomics company, providing superior technology and software for highly multiplexed protein quantification. Biognosys has partnered closely with us to provide high-sensitivity and specificity proteomics analysis to characterize our 3D InSight™ Microtissue functionality and provide ground-breaking insights into toxicity and efficacy omics applications.
CSEM is an internationally recognized Swiss innovation leader that develops and transfers disruptive technologies with a high societal impact and multiple industry applications.
Hamilton Bonaduz AG is a leading global manufacturer for automated workstations for liquid handling and laboratory automation technology to the scientific community. Hamilton products are known for their advances in life sciences and biotechnology, offering reliability, performance and flexibility. We leverage the MagPip™ technology on the Microlab VANTAGE ™, which allows us to do automated fast and accurate liquid transfer in our proprietary spheroid microplates.
INTEGRA is a leading provider of high-quality laboratory tools for liquid handling, media preparation, sterilization, and cell cultivation. The company commits to creating innovative solutions which that fulfill the customer needs in research, diagnostics, and quality control within the life science markets and medical industry. Our partnership with INTEGRA is based on providing high-performance liquid-handling solutions for 3D cell culture.
KML Vision's IKOSA Platform empowers life science researchers with an intuitive, no-code AI solution. It enables the creation of custom bioimage analysis apps, automating workflows for time efficiency and unbiased, accurate results. Insphero’s 3D microtissues contain an extensive amount of information on human physiology and disease states and how treatments impact them. With the IKOSA Platform of KML Vision, we have a tool that allows us to extract insights in a fast and reliable way.
One of the world’s most trusted providers of luminescent and fluorescent-based assay providers, Promega has worked closely with us since 2010 to validate and optimize assays for use with 3D microtissues, including CellTiter-Glo® ATP assays, LDH and apoptosis assays, as well as high-quality RNA extraction from InSphero microtissues.
We partner with Yokogawa to develop methods for imaging and analysis of 3D and 4D microtissues using the CellVoyager™ High-Content Imaging family of products, including the bench-top CQ1 instrument as well as the high-throughput CV8000 system for advanced toxicology and efficacy testing applications. Image acquisition is supplemented by the analysis software suite CellPathfinder™, which incorporates machine learning and deep learning.
InSphero's collaboration with esteemed academic institutions underscores our dedication to advancing scientific frontiers. These partnerships facilitate the exchange of knowledge, resources, and expertise, fostering a fertile ground for innovation with the potential to shape the future of drug development.
Medical University of Innsbruck, Austria
Dr. Arno Ammann, Laboratory for Molecular Cell Biology
Prof. Dr. Alain G. Zeimet, Department of Obstetrics and Gynecology
Vrije Universiteit Brussel (VUB)
Professor Leo van Grunsven, Head of the VUB Liver Cell Biology Research Laboratory
R&D Publicly-funded projects
InSphero's engagement with publicly funded R&D projects exemplifies our commitment to driving innovation in a collaborative ecosystem. We contribute our expertise to accelerate the development of breakthrough solutions and to amplify their reach and impact. By bridging the gap between academia, industry, and public sector research, InSphero plays a pivotal role in shaping the landscape of research that holds the potential to transform multiple facets of human health and scientific understanding.
Eurostars supports international innovative projects led by research and development- performing small- and medium-sized enterprises (R&D-performing SMEs).
Innosuisse is the Swiss Innovation Agency. Its role is to promote science-based innovation in the interest of the economy and society in Switzerland.
Moore4Medical accelerates innovation in electronic medical devices. The project addresses emerging medical applications and technologies that offer significant new opportunities for patients as well as for industry including: bioelectronic medicines, organ-on-chip, drug adherence monitoring, smart ultrasound, radiation free interventions and continuous monitoring.
PATROLS - Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment
PATROLS is an international project combining a team of academics, industrial scientists, government officials and risk assessors to deliver advanced and realistic tools and methods for nanomaterial safety assessment
As a member of prestigious life science organizations, InSphero is actively involved in the advancement of drug discovery science, demonstrating our commitment to fostering continuous discussions and knowledge-sharing. By participating in these organizations, we gain collaborate with thought leaders, experts, and industry peers, which enhances the mutual ability to stay at the forefront of emerging trends and technologies.
Swiss Biotech Association
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources.
Toolpoint for Lab Science
Toolpoint for Lab Science is a vertically integrated cluster that brings together the skills and expertise of the laboratory automation industry in Europe. Founded in 2003 by companies in the Greater Zurich Area, it now brings together companies, universities, research institutes and partners with the aim of making lab processes more effective and efficient – from sample collection to the use of results.
The Society for Laboratory Automation and Screening (SLAS)
The Society for Laboratory Automation and Screening (SLAS) is an international professional society of academic, industry and government researchers as well as developers and providers of laboratory automation technology and tools. In 2023, InSphero’s CEO and Co-founder, Dr. Jan Lichtenberg was appointed as the President of the SLAS Board of Directors.
Society of Toxicology
Founded in 1961, the Society of Toxicology (SOT) is a professional and scholarly organization of scientists from academic institutions, government, and industry representing the great variety of scientists who practice toxicology in the US and abroad. The Society’s mission is to create a safer and healthier world by advancing the science and increasing the impact of toxicology.